What does CUSIP 137404109 represent in this 13F holders report?

CUSIP 137404109 is the security identifier for CADL - Candel Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CADL - Candel Therapeutics, Inc. - Common Stock in Q1 2024?

18 institutional investors reported CADL - Candel Therapeutics, Inc. - Common Stock for Q1 2024. Use the holders table for investor-level position and value details.

Candel Therapeutics, Inc. - Common Stock (CADL)

CUSIP: 137404109

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock
Total 13F shares: 3,780,257
Total 13F value: $5,972,529
Share change: -169,992
SEC-reported price per share: $1.58
Number of holders: 18
Value change: -$231,572
Number of buys: 9
Number of sells: 10
Shares outstanding: 73,256,045

Security key

137404109

Report period

Q1 2024

Institutions

Top holders

CADL full security history Ownership snapshot Full 13F holder table Candel Therapeutics, Inc. SEC filings Candel Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CADL - Candel Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Northpond Ventures, LLC

Disclosed value leader

Northpond Ventures, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2023

13F Lead comparable stake: 2.6% Showing 1-6 of 15 holder rows.

Quick read

Northpond Ventures, LLC leads the comparable SEC ownership view at 2.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Northpond Ventures, LLC's linked filing trail.

Comparable ownership Top 5

Northpond Ventures, LLC 2.6%

Sands Capital Alternatives, LLC 1.1%

VANGUARD GROUP INC 0.58%

FMR LLC 0.41%

GEODE CAPITAL MANAGEMENT, LLC 0.19%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Northpond Ventures, LLC	13F Company 13F	2.6%	$2,844,766 1,935,215 shares	—	31 Dec 2023
Sands Capital Alternatives, LLC	13F Company 13F	1.1%	$1,193,253 811,737 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	0.58%	$625,851 425,749 shares	—	31 Dec 2023
FMR LLC	13F Company 13F	0.41%	$438,624 298,384 shares	—	31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.19%	$204,737 139,253 shares	—	31 Dec 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F Company 13F	0.18%	$194,915 132,595 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,780,257

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %